United States

Medicines Co (MDCO.O)

MDCO.O on Nasdaq

27 Oct 2016
Change (% chg)

$-2.38 (-6.55%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Wed, Oct 26 2016

BRIEF-Medicines Q3 revenue $37.6 mln versus I/B/E/S view $37.3 mln

* The medicines company reports third-quarter 2016 financial results

BRIEF-China National Accord Medicines to buy 30 pct stake in unit at 3.5 mln yuan

* Says it plans to acquire 30 percent stake in its 70 percent owned unit, at price of 3.5 million yuan

BRIEF-Medicines Co announces positive top-line results from day 90 interim analysis in ongoing Orion-1 Phase 2 study of PCSK9si

* Medicines company announces positive top-line results from day 90 interim analysis in ongoing orion-1 phase 2 study of pcsk9si

BRIEF-The Medicines Company says provides update on PCSK9si study

Oct 5 The Medicines Company Provides Progress Update On Ongoing Orion

BRIEF-Medicines Co receives funding of up to $132 mln from BARDA

* Awarded up to $132 million to develop portfolio of new antibiotics targeting drug-resistant infections under strategic partnership with BARDA

U.S. to invest in Medicines Co, Roche antibiotics development

Sept 21 The Medicines Co on Wednesday said it will receive up to $132 million in U.S. government funding for development of new antibiotics to fight drug-resistant infections, seen by health officials as a critically important need.

BRIEF-Medicines company provides update on Dyslipidemia programs

* The medicines company provides update on Dyslipidemia programs

BRIEF-The Medicines Co reports Q2 earnings per share of $2.51 from continuing operations

* Q2 adjusted loss per share $0.62 from continuing operations

BRIEF-Medicines Co gives Federal circuit rules for Medicines Co in Angiomax litigation

* Federal circuit rules for medicines company in angiomax patent litigation

Medicines Co's antibiotic succeeds in late-stage trial

The Medicines Co said its experimental antibiotic met the main goals of a late-stage trial on patients with complicated urinary tract infections.

Select another date: